Influenza Vaccine Revaccination in Ambulatory Elderly Subjects

NCT00775450 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

807

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Orthomyxovirus Infection
Myxovirus Infection

Interventions

BIOLOGICAL: Influenza Virus Vaccine USP Trivalent Types A and B
BIOLOGICAL: Influenza Virus Vaccine USP Trivalent Types A and B
BIOLOGICAL: Influenza Virus Vaccine USP Trivalent Types A and B
BIOLOGICAL: Influenza Virus Vaccine USP Trivalent Types A and B
BIOLOGICAL: Influenza Virus Vaccine USP Trivalent Types A and B

Sponsor

Sanofi Pasteur, a Sanofi Company